[HTML][HTML] Outbreak response strategies with type 2-containing oral poliovirus vaccines
DA Kalkowska, SGF Wassilak, MA Pallansch… - Vaccine, 2023 - Elsevier
Despite exhaustive and fully-financed plans to manage the risks of globally coordinated
cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of …
cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of …
[HTML][HTML] Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response
DA Kalkowska, MA Pallansch, SGF Wassilak, SL Cochi… - Vaccine, 2023 - Elsevier
Abstract The Global Polio Eradication Initiative (GPEI) faces substantial challenges with
managing outbreaks of serotype 2 circulating vaccine-derived polioviruses (cVDPV2s) in …
managing outbreaks of serotype 2 circulating vaccine-derived polioviruses (cVDPV2s) in …
Updated characterization of outbreak response strategies for 2019–2029: impacts of using a novel type 2 oral poliovirus vaccine strain
DA Kalkowska, MA Pallansch, A Wilkinson… - Risk …, 2021 - Wiley Online Library
Delays in achieving the global eradication of wild poliovirus transmission continue to
postpone subsequent cessation of all oral poliovirus vaccine (OPV) use. Countries must stop …
postpone subsequent cessation of all oral poliovirus vaccine (OPV) use. Countries must stop …
[HTML][HTML] Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation
KM Thompson, DA Kalkowska… - Frontiers in Public …, 2023 - frontiersin.org
Introduction Detection of poliovirus transmission and ongoing oral poliovirus vaccine (OPV)
use continue to delay poliomyelitis eradication. In 2016, the Global Polio Eradication …
use continue to delay poliomyelitis eradication. In 2016, the Global Polio Eradication …
[HTML][HTML] Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
RJ Duintjer Tebbens, MA Pallansch… - BMC Infectious …, 2016 - Springer
Background Following successful eradication of wild polioviruses and planned globally-
coordinated cessation of oral poliovirus vaccine (OPV), national and global health leaders …
coordinated cessation of oral poliovirus vaccine (OPV), national and global health leaders …
[HTML][HTML] Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020
GR Macklin, AK Goel, O Mach, G Tallis, JA Ahmed… - Vaccine, 2023 - Elsevier
The number and geographic breadth of circulating vaccine-derived poliovirus type 2
(cVDPV2) outbreaks detected after the withdrawal of type 2 containing oral polio vaccine …
(cVDPV2) outbreaks detected after the withdrawal of type 2 containing oral polio vaccine …
[HTML][HTML] Maintenance and intensification of bivalent oral poliovirus vaccine use prior to its coordinated global cessation
RJD Tebbens, LM Hampton, SGF Wassilak… - Journal of vaccines & …, 2016 - ncbi.nlm.nih.gov
Objective To examine the impact of different bivalent oral poliovirus vaccine (bOPV)
supplemental immunization activity (SIA) strategies on population immunity to serotype 1 …
supplemental immunization activity (SIA) strategies on population immunity to serotype 1 …
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences
DA Kalkowska, SGF Wassilak, E Wiesen… - Risk …, 2024 - Wiley Online Library
Due to the very low, but nonzero, paralysis risks associated with the use of oral poliovirus
vaccine (OPV), eradicating poliomyelitis requires ending all OPV use globally. The Global …
vaccine (OPV), eradicating poliomyelitis requires ending all OPV use globally. The Global …
Lessons from globally coordinated cessation of serotype 2 oral poliovirus vaccine for the remaining serotypes
KM Thompson… - The Journal of infectious …, 2017 - academic.oup.com
Background. Comparing model expectations with the experience of oral poliovirus vaccine
(OPV) containing serotype 2 (OPV2) cessation can inform risk management for the expected …
(OPV) containing serotype 2 (OPV2) cessation can inform risk management for the expected …
[HTML][HTML] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
RJ Duintjer Tebbens, KM Thompson - BMC Infectious Diseases, 2015 - Springer
Abstract Background The Global Polio Eradication Initiative plans for coordinated cessation
of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (ie, OPV2 …
of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (ie, OPV2 …